EXGM
NRST
Market cap19mUSD
Sep 16, Last price
0.58EUR
1D
-10.69%
1Q
-10.00%
Jan 2017
-78.73%
IPO
-72.41%
Name
Neurosoft Software Production SA
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Neurosoft Software Production S.A. is an Information and Communications Technology (ICT) firm specializing in the creation, enhancement, and ongoing support of comprehensive software solutions. Its expertise spans financial technology (Fintech), data analytics, systems architecture, and advanced cybersecurity operations, serving clients both within Greece and across the globe. Among its diverse product portfolio are Proxima+, a platform facilitating sales and supply chain financing; Angel, designed to safeguard maritime operations and onboard networks through monitoring, threat detection, and access control; and Illicium, a cutting-edge cyber deception solution. Further offerings include Neutrify, a comprehensive cybersecurity defense center that actively tracks, identifies, neutralizes, and investigates digital threats; RedyOps, a service focused on assessing organizational security posture and bolstering defenses against multifaceted attacks targeting personnel, technology, and physical infrastructure; and Enterprise Link, which delivers streamlined, secure cloud connectivity management through application-aware policies and network segmentation. Established in 1994, the company operates from its main office located in Athens, Greece.
Key people
Nikos Vasilonikolidakis
Chief Executive Officer, Director
Leonidas Dimitroulias
Head Accountant
Mavroeidis Angelopoulos
Chairman of the Board · since 2002
Evangelos Kollias
Director · since 2017
Athanasios Rigas
Director
Non-Executive Director · since 2016
Ioannis V. Papanikolaou
Independent Director · since 2011
Headquarters & legal address
466 IRAKLIOU AVEN & KIPROU
N. IRAKLEIO, I 141 22
GR
N. IRAKLEIO, I 141 22
GR
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||